Minerva Neurosciences, Inc. SEC filings NERV
Minerva Neurosciences, Inc. has 645 filings in SEC EDGAR's recent list, going back to Feb 14, 2014. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Aug 12, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2026 | Aug 7, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
May 27, 2026 | May 27, 2026 |
| 424B5 | Prospectus supplement | May 27, 2026 | — |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 3, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Other events
|
Apr 6, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Apr 2, 2026 | Mar 30, 2026 |
| EFFECT | Filing | Mar 19, 2026 | — |
| CORRESP | Letter to the SEC | Mar 17, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2026 | — |
| S-3 | Shelf registration | Mar 11, 2026 | — |
| 10-K | Annual report | Mar 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 3, 2026 | Feb 3, 2026 |
| EFFECT | Filing | Jan 6, 2026 | — |
| 424B3 | Prospectus | Jan 6, 2026 | — |
| CORRESP | Letter to the SEC | Jan 2, 2026 | — |
| UPLOAD | Letter from the SEC | Dec 31, 2025 | — |
| S-8 | Employee stock plan registration | Dec 23, 2025 | — |
| S-3 | Shelf registration | Dec 23, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 22, 2025 | Dec 22, 2025 |
| ARS | Annual report to shareholders | Nov 24, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Nov 24, 2025 | Dec 22, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 19, 2025 | Nov 14, 2025 |
| PRE 14A | Preliminary proxy statement | Nov 14, 2025 | Dec 22, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 22, 2025 | Oct 21, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 10-K/A | Amended annual report | Apr 29, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Apr 21, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Mar 19, 2025 | Mar 17, 2025 |
| 10-K | Annual report | Feb 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Jan 13, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 5, 2024 | Dec 5, 2024 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Oct 22, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Oct 22, 2024 | — |
| DEF 14A | Proxy statement | Oct 22, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 11, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Other events
|
Sep 16, 2024 | Sep 14, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change
|
May 30, 2024 | May 29, 2024 |
| 10-Q | Quarterly report | May 1, 2024 | Mar 31, 2024 |
| 10-K/A | Amended annual report | Apr 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice
|
Apr 12, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Other events
|
Feb 27, 2024 | Feb 26, 2024 |
| 10-K/A | Amended annual report | Feb 26, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 28, 2023 | Sep 27, 2023 |
| ARS | Annual report to shareholders | Aug 15, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Aug 15, 2023 | — |
| DEF 14A | Proxy statement | Aug 15, 2023 | Sep 27, 2023 |
| EFFECT | Filing | Aug 9, 2023 | — |
| 424B3 | Prospectus | Aug 9, 2023 | — |
| CORRESP | Letter to the SEC | Aug 7, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2023 | — |
| S-3 | Shelf registration | Aug 4, 2023 | — |
| 10-Q | Quarterly report | Aug 1, 2023 | Jun 30, 2023 |
| D | Filing | Jul 3, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 28, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Other events
|
Jun 20, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Listing notice
|
Jun 2, 2023 | May 31, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Officer or director change
|
May 5, 2023 | May 3, 2023 |
| 8-K |
Current report
Other events
|
May 1, 2023 | May 1, 2023 |
| 10-K/A | Amended annual report | Apr 20, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 8, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Dec 28, 2022 | Dec 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2022 | Dec 13, 2022 |
| 8-K |
Current report
Listing notice
|
Dec 2, 2022 | Dec 1, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Oct 17, 2022 | Oct 14, 2022 |
| EFFECT | Filing | Sep 23, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2022 | — |
| CORRESP | Letter to the SEC | Sep 21, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2022 | — |
| S-3 | Shelf registration | Sep 14, 2022 | — |
| CORRESP | Letter to the SEC | Sep 14, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2022 | — |
| 8-K |
Current report
Listing notice
|
Sep 9, 2022 | Sep 8, 2022 |
| 8-K |
Current report
Other events
|
Aug 22, 2022 | Aug 22, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 17, 2022 | Jun 17, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 10, 2022 |
| 10-Q | Quarterly report | May 4, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 10, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2022 | Apr 13, 2022 |
| 8-K |
Current report
Other events
|
Apr 7, 2022 | Apr 7, 2022 |
| 8-K |
Current report
Listing notice
|
Mar 14, 2022 | Mar 8, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Other events
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Listing notice
|
Jan 18, 2022 | Jan 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2022 | Jan 5, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2021 | Dec 8, 2021 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Other events
|
Nov 3, 2021 | Nov 3, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 12, 2021 | Oct 11, 2021 |
| 8-K |
Current report
Other events
|
Sep 30, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 8, 2021 | Sep 2, 2021 |
| SC TO-I/A | Filing | Aug 9, 2021 | — |
| SC TO-I/A | Filing | Aug 2, 2021 | — |
| 10-Q | Quarterly report | Aug 2, 2021 | Jun 30, 2021 |
| SC TO-I | Filing | Jul 6, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2021 | Jun 11, 2021 |
| 10-Q | Quarterly report | May 12, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 11, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2021 | Jun 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 19, 2021 | Apr 13, 2021 |
| 10-K | Annual report | Mar 8, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Material agreement
|
Jan 19, 2021 | Jan 19, 2021 |
| 8-K |
Current report
Other events
|
Dec 1, 2020 | Dec 1, 2020 |
| 10-Q | Quarterly report | Nov 2, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 14, 2020 | Oct 9, 2020 |
| 8-K |
Current report
Other events
|
Sep 8, 2020 | Sep 8, 2020 |
| S-8 | Employee stock plan registration | Aug 7, 2020 | — |
| 10-Q | Quarterly report | Aug 3, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Material agreement, Agreement ended, Other events
|
Jul 1, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2020 | Jun 19, 2020 |
| 8-K |
Current report
Other events
|
Jun 5, 2020 | Jun 5, 2020 |
| 8-K |
Current report
Other events
|
May 29, 2020 | May 29, 2020 |
| 10-Q | Quarterly report | May 4, 2020 | Mar 31, 2020 |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 19, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 1, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Other events
|
Mar 13, 2020 | Mar 12, 2020 |
| 8-K |
Current report
Other events
|
Mar 9, 2020 | Jan 6, 2020 |
| 10-K | Annual report | Mar 9, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Feb 5, 2020 | Feb 5, 2020 |
| 8-K |
Current report
Other events
|
Jan 6, 2020 | Jan 6, 2020 |
| 8-K |
Current report
Other events
|
Dec 18, 2019 | Dec 18, 2019 |
| 10-Q | Quarterly report | Nov 4, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Other events
|
Oct 1, 2019 | Oct 1, 2019 |
| 8-K |
Current report
Material agreement
|
Sep 24, 2019 | Sep 18, 2019 |
| 10-Q | Quarterly report | Aug 5, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Other events
|
Jun 26, 2019 | Jun 24, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2019 | May 31, 2019 |
| 8-K |
Current report
Other events
|
May 16, 2019 | May 13, 2019 |
| 10-Q | Quarterly report | May 6, 2019 | Mar 31, 2019 |
| DEFA14A | Additional proxy material | Apr 17, 2019 | — |
| DEF 14A | Proxy statement | Apr 17, 2019 | May 31, 2019 |
| RW | Filing | Apr 11, 2019 | — |
| 10-K | Annual report | Mar 12, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Nov 5, 2018 | Sep 30, 2018 |
| EFFECT | Filing | Aug 24, 2018 | — |
| CORRESP | Letter to the SEC | Aug 22, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2018 | — |
| S-3 | Shelf registration | Aug 10, 2018 | — |
| 10-Q | Quarterly report | Aug 2, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2018 | Jul 16, 2018 |
| S-8 | Employee stock plan registration | Jun 15, 2018 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2018 | Jun 7, 2018 |
| 10-Q | Quarterly report | May 3, 2018 | Mar 31, 2018 |
| DEFA14A | Additional proxy material | Apr 24, 2018 | — |
| DEF 14A | Proxy statement | Apr 24, 2018 | Jun 7, 2018 |
| 8-K |
Current report
Other events
|
Mar 22, 2018 | Mar 22, 2018 |
| S-8 | Employee stock plan registration | Mar 12, 2018 | — |
| 10-K | Annual report | Mar 12, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Other events
|
Feb 21, 2018 | Feb 21, 2018 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 5, 2018 | Jan 31, 2018 |
| 8-K |
Current report
Other events
|
Jan 8, 2018 | Jan 8, 2018 |
| S-8 | Employee stock plan registration | Dec 29, 2017 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 15, 2017 | Dec 13, 2017 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Dec 11, 2017 | Dec 11, 2017 |
| 8-K |
Current report
Officer or director change
|
Dec 11, 2017 | Dec 10, 2017 |
| 10-Q | Quarterly report | Nov 6, 2017 | Sep 30, 2017 |
| 8-K |
Current report
Material agreement
|
Oct 6, 2017 | Oct 2, 2017 |
| 8-K |
Current report
Officer or director change
|
Sep 8, 2017 | Sep 6, 2017 |
| 8-K |
Current report
Other events
|
Aug 25, 2017 | Aug 25, 2017 |
| 10-Q | Quarterly report | Aug 3, 2017 | Jun 30, 2017 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 24, 2017 | Jul 20, 2017 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 29, 2017 | Jun 28, 2017 |
| 424B5 | Prospectus supplement | Jun 29, 2017 | — |
| 424B5 | Prospectus supplement | Jun 27, 2017 | — |
| 8-K |
Current report
Material agreement
|
Jun 14, 2017 | Jun 13, 2017 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2017 | Jun 1, 2017 |
| 8-K |
Current report
Material agreement
|
May 31, 2017 | May 30, 2017 |
| 8-K |
Current report
Other events
|
May 15, 2017 | May 15, 2017 |
| 10-Q | Quarterly report | May 4, 2017 | Mar 31, 2017 |
| DEFA14A | Additional proxy material | Apr 18, 2017 | — |
| DEF 14A | Proxy statement | Apr 18, 2017 | Jun 1, 2017 |
| 8-K |
Current report
Other events
|
Mar 21, 2017 | Mar 16, 2017 |
| S-8 | Employee stock plan registration | Mar 13, 2017 | — |
| 10-K | Annual report | Mar 13, 2017 | Dec 31, 2016 |
| 8-K |
Current report
Other events
|
Feb 27, 2017 | Feb 27, 2017 |
| 8-K |
Current report
Other events
|
Jan 20, 2017 | Jan 20, 2017 |
| 8-K |
Current report
Other events
|
Jan 6, 2017 | Jan 6, 2017 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2016 | Dec 14, 2016 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NERV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Burlington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1598646
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.